Free Trial
OTCMKTS:PTNT

Palatin Technologies (PTNT) Stock Price, News & Analysis

Palatin Technologies logo
$24.41 -0.40 (-1.62%)
As of 11/16/2026

About Palatin Technologies Stock (OTCMKTS:PTNT)

Advanced

Key Stats

Today's Range
$24.41
▼
$24.41
50-Day Range
$23.83
▼
$25.27
52-Week Range
$23.83
▼
$28.06
Volume
15 shs
Average Volume
667 shs
Market Capitalization
$976.40 thousand
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Palatin Technologies is a biopharmaceutical company focused on developing medicines that act on melanocortin and other peptide-receptor systems. Its research has targeted conditions in areas including sexual health, inflammation and eye disease.

The company’s best-known product is Vyleesi (bremelanotide), a prescription treatment approved in the United States for acquired, generalized hypoactive sexual desire disorder in premenopausal women. Palatin has also pursued investigational candidates for inflammatory conditions and dry eye disease; these candidates are not approved treatments.

Palatin is based in the United States and has used licensing and development partnerships to advance and commercialize its products. The availability and commercial rights for its therapies may vary by geography.

AI Generated. May Contain Errors.

Receive PTNT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Palatin Technologies and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

PTNT Stock News Headlines

Drop these 5 stocks before the market opens tomorrow!
The Wall Street Journal called it the "$64 trillion question": is a stock market crash on the way? Weiss Ratings' latest research says 2026 could be very rough for some well-known stocks. A major shift now taking shape in the market could hit some of America's most-loved names hard. Weiss analysts have pinpointed five stocks they believe investors should steer clear of while it plays out.tc pixel
See More Headlines

PTNT Stock Analysis - Frequently Asked Questions

Palatin Technologies' stock was trading at $5.60 on January 1st, 2026. Since then, PTNT shares have increased by 335.9% and is now trading at $24.41.

Palatin Technologies, Inc. (OTCMKTS:PTNT) issued its quarterly earnings data on Wednesday, May, 15th. The biopharmaceutical company reported ($26.50) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($25.00) by $1.50.
Read the conference call transcript
.

Palatin Technologies's stock reverse split before market open on Tuesday, August 12th 2025.The 1-50 reverse split was announced on Tuesday, August 12th 2025. The number of shares owned by shareholders was adjusted after the market closes on Tuesday, August 12th 2025. An investor that had 100 shares of stock prior to the reverse split would have 2 shares after the split.

Shares of PTNT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Palatin Technologies investors own include NVIDIA (NVDA), Micron Technology (MU), NIO (NIO), Alibaba Group (BABA), Tesla (TSLA), Advanced Micro Devices (AMD) and Sorrento Therapeutics (SRNE).

Company Calendar

Today
11/16/2026
Fiscal Year End
6/30/2027

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Industry
Biotechnology
Sub-Industry
Biotechnology
Current Symbol
OTCMKTS:PTNT
Previous Symbol
PINK:PTNT
CIK
911216
Employees
30
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($60.00)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$29.74 million
Net Margins
N/A
Pretax Margin
-1,590.66%
Return on Equity
N/A
Return on Assets
-365.57%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.38
Quick Ratio
0.38

Sales & Book Value

Annual Sales
$4.49 million
Price / Sales
0.22
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($0.25) per share
Price / Book
-97.64

Miscellaneous

Outstanding Shares
40,000
Free Float
18,160,000
Market Cap
$976.40 thousand
Optionable
Not Optionable
Beta
-1.04
Don't Wait for the OpenAI IPO Cover

The AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.

Get This Free Report

This page (OTCMKTS:PTNT) was last updated on 11/16/2026 by MarketBeat.com Staff.
From Our Partners